Developing a Patient-Centered Benefit-Risk Survey- A Community-Engaged Process

Sep 1, 2016, 00:00
10.1016/j.jval.2016.02.014
https://www.valueinhealthjournal.com/article/S1098-3015(16)00061-9/fulltext
Title : Developing a Patient-Centered Benefit-Risk Survey- A Community-Engaged Process
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)00061-9&doi=10.1016/j.jval.2016.02.014
First page : 751
Section Title : Themed Section: Incorporating Patient Preferences into Regulatory Decision Making
Open access? : No
Section Order : 7

Objectives

To provide a community-engaged process to inform the design of a stated-preferences experiment. The process involved integrating patients and caregivers of people with Duchenne/Becker muscular dystrophy, advocates, clinicians, and the sponsor in conceptualizing and developing a benefit-risk survey on the basis of phase III trial results.

Methods

Our community-engagement process for the development of a stated-preference survey included a set of five guiding principles with a foundation in the principles of community-engaged research. Engagement efforts were carried out through an informal network of three committees. Members of the leadership, stakeholder, and review committees comprised patients, caregivers, clinicians, advocacy leadership, and industry representatives.

Results

Committee members participated in 15 hours of formal engagement including interviews and conference calls that ranged from 45 to 90 minutes, plus additional less-formal ad hoc communication. Committees comprised 20 individuals across three committees including adults with DMD (n = 6), parents of children with DMD (n = 6), clinicians (n = 3), members of research and advocacy organizations (n = 4), and an industry representative (n = 1). Community engagement informed attribute selection, survey length, word choice, and eligibility criteria. Challenges in the process included managing diverse stakeholder perspectives, time requirements, and the inherent tension between outcomes used in clinical trials versus attributes that correspond to patient- and family-relevant outcomes.

Conclusions

We demonstrated how community engagement can successfully influence study design to support the design of a relevant survey instrument that is ethical, acceptable, meaningful to the community, and enhances patient-centered benefit-risk assessment for regulatory decision making.

Categories :
  • Health Policy & Regulatory
  • Patient Engagement
  • Patient-Centered Research
  • Pricing Policy & Schemes
  • Reimbursement & Access Policy
Tags :
  • attribute development
  • community engagement
  • patient-centered benefit risk
  • stated preferences
Regions :
  • North America
ViH Article Tags :